Spero Therapeutics
Latest round
- Series C
Last raised
- Mar 2017
Total raised
- $112M
Investors
- 10
About Spero Therapeutics
Spero Therapeutics, Inc.Founded in 2013, Spero Therapeutics, Inc. is engaged in developing treatments for patients with complex infections. The company, headquartered in Cambridge, US, was co-founded by Ankit Mahadevia, Laurence Rahme, and Milind Deshpande.Spero Therapeutics primarily focuses on creating innovative therapies for patients with rare diseases and multidrug-resistant bacterial infections. The core product, Tebipenem HBr, is an investigational oral carbapenem antibiotic intended for treating complicated urinary tract infections (cUTIs).36 mn.Spero Therapeutics plans to advance the development of Tebipenem HBr and other future products designed to target rare diseases and multidrug-resistant infections. The management seeks to enter new geographic markets to enhance patient access to effective treatments.
Who invested in Spero Therapeutics
10 investors across 3 rounds
See all investors in Spero Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Spero Therapeutics
Who invested in Spero Therapeutics?
Spero Therapeutics has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Spero Therapeutics raised?
Spero Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Spero Therapeutics last raise money?
Spero Therapeutics's most recent round on record is a Series C, in Mar 2017.
What does Spero Therapeutics do?
Spero Therapeutics is a biotechnology company.
Where is Spero Therapeutics headquartered?
Spero Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Spero Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Spero Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Spero Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.